Bristol-Myers Squibb Company (BIT:1BMY)

Italy flag Italy · Delayed Price · Currency is EUR
38.95
+0.16 (0.41%)
At close: Aug 8, 2025, 5:30 PM CET
-9.64%
Market Cap 83.14B
Revenue (ttm) 40.62B
Net Income (ttm) 4.30B
Shares Out n/a
EPS (ttm) 2.12
PE Ratio 19.34
Forward PE 7.45
Dividend 1.69 (4.35%)
Ex-Dividend Date Jul 2, 2025
Volume 206
Average Volume 149
Open 38.85
Previous Close 38.79
Day's Range 38.85 - 39.31
52-Week Range 37.78 - 60.00
Beta n/a
RSI 57.75
Earnings Date Jul 31, 2025

About BIT:1BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Borsa Italiana
Ticker Symbol 1BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.